Skip to content
Certified ManufacturersFor manufacturers

We Make Vitamins LLC

Lakeland, FL, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

We Make Vitamins LLC is a dietary supplement manufacturer in Lakeland, FL, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 2715 Badger Road, Lakeland, FL 33811, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Tablet Compression
    • Warehousing

How We Make Vitamins LLC compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name We Make Vitamins LLC in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 6 food or dietary supplement inspections at facilities matching We Make Vitamins LLC, from 2013 to 2026, as of . All 6 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    1 citation posted:

    • Packaging - specifications (21 CFR 111.410(a))
    Full citation text
    • Packaging - specifications (21 CFR 111.410(a))

      You did not take necessary actions to determine whether packaging for dietary supplements meets specifications so that the condition of the packaging will ensure the quality of your dietary supplements.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    3 citations posted:

    • Equipment - controls - QC (21 CFR 111.30(e))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    Full citation text
    • Equipment - controls - QC (21 CFR 111.30(e))

      Your quality control personnel did not approve controls established to ensure that automated, mechanical, or electronic equipment functions in accordance with its intended use.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    3 citations posted:

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - contamination limits (21 CFR 111.70(b)(3))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    Full citation text
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity and strength.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the purity, strength and composition of the finished dietary supplement.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    4 citations posted:

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    • Batch record - complete (21 CFR 111.255(b))
    • Written procedures, laboratory operations (21 CFR 111.325(a))
    Full citation text
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Written procedures, laboratory operations (21 CFR 111.325(a))

      You did not make and keep written procedures for laboratory operations.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    7 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    See all 7 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, and labeling dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength, and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Instructions; specifications; quality (21 CFR 111.210(h)(1))

      The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Written procedures - laboratory operations (21 CFR 111.303)

      You did not establish and follow written procedures for laboratory operations.

    • Records - packaging, labeling operations (21 CFR 111.430(b))

      You did not make and keep records of the written procedures for packaging and labeling operations.

    FEI 3004309576

Show all 6 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    1 citation posted:

    • Packaging - specifications (21 CFR 111.410(a))
    Full citation text
    • Packaging - specifications (21 CFR 111.410(a))

      You did not take necessary actions to determine whether packaging for dietary supplements meets specifications so that the condition of the packaging will ensure the quality of your dietary supplements.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    3 citations posted:

    • Equipment - controls - QC (21 CFR 111.30(e))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    Full citation text
    • Equipment - controls - QC (21 CFR 111.30(e))

      Your quality control personnel did not approve controls established to ensure that automated, mechanical, or electronic equipment functions in accordance with its intended use.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength and composition of the finished dietary supplement.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    3 citations posted:

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - contamination limits (21 CFR 111.70(b)(3))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    Full citation text
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity and strength.

    • Specifications - contamination limits (21 CFR 111.70(b)(3))

      You did not establish limits for contamination that may adulterate or may lead to adulteration of the finished dietary supplement.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the purity, strength and composition of the finished dietary supplement.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    4 citations posted:

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    • Batch record - complete (21 CFR 111.255(b))
    • Written procedures, laboratory operations (21 CFR 111.325(a))
    Full citation text
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    • Written procedures, laboratory operations (21 CFR 111.325(a))

      You did not make and keep written procedures for laboratory operations.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    7 citations posted:

    • Personnel - education, training, experience (21 CFR 111.12(c))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    See all 7 citations
    • Personnel - education, training, experience (21 CFR 111.12(c))

      Personnel engaged in manufacturing, packaging, and labeling dietary supplements do not have the education, training, or experience to perform the person's assigned functions.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength, and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Instructions; specifications; quality (21 CFR 111.210(h)(1))

      The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Written procedures - laboratory operations (21 CFR 111.303)

      You did not establish and follow written procedures for laboratory operations.

    • Records - packaging, labeling operations (21 CFR 111.430(b))

      You did not make and keep records of the written procedures for packaging and labeling operations.

    FEI 3004309576

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Lakeland, Florida

    9 citations posted:

    • Procedures - calibrating automated, mechanical equip (21 CFR 111.25(b))
    • Equipment - automated - calibrate, inspect (21 CFR 111.30(c))
    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    See all 9 citations
    • Procedures - calibrating automated, mechanical equip (21 CFR 111.25(b))

      You did not establish written procedures for calibrating, inspecting, and checking automated, mechanical, and electronic equipment.

    • Equipment - automated - calibrate, inspect (21 CFR 111.30(c))

      You did not routinely calibrate the automated, mechanical, or electronic equipment to ensure proper performance.

    • Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))

      You did not establish component specifications for purity, strength, and composition.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Quality control operations - tests, examinations; results (21 CFR 111.110(c))

      Your quality control operations did not include reviewing and approving the results of required tests.

    • Quality control operations - quarantine (21 CFR 111.120(e))

      Your quality control operations did not include approving, and releasing from quarantine, all components and packaging before they were used.

    • Written procedures - tests, examinations; specifications met (21 CFR 111.303)

      You did not establish written procedures for the tests and examinations conducted to determine whether specifications are met.

    • Written procedures -packaging operations (21 CFR 111.403)

      You did not establish written procedures for packaging operations.

    FEI 3004309576

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026